Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Advance Publication


First published on October 29, 2008
A more recent version of this article appeared on January 1, 2009
Neuro Oncol 2008, DOI:10.1215/15228517-2008-085
This Article
Right arrow Advance Publication Full Text (PDF)
Right arrow All Versions of this Article:
11/2/122    most recent
15228517-2008-085v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siegelin, M. D.
Right arrow Articles by von Deimling, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Copyright 2008 by the Society for Neuro-Oncology

Received November 12, 2007
Accepted April 29, 2008

Basic and Translational Investigations

Quercetin promotes degradation of survivin and thereby enhances death-receptor mediated apoptosis in glioma cells

Markus D. Siegelin 1, David E. Reuss 1, Antje Habel 1, Abdelhaq Rami 2, Andreas von Deimling 3*

1 Department of Neuropathology, University Hospital Heidelberg, Im Neuenheimer Feld 220, 69120 Heidelberg
2 Institut für Zelluläre und Molekulare Anatomie (III), Klinikum der Johann Wolfgang von Goethe-Universität, Theodor Stern Kai 7, 60590 Frankfurt/Main
3 Department of Neuropathology, University Hospital Heidelberg, Im Neuenheimer Feld 220, 69120 Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Center (DKFZ), Im Neuenheimer Feld 220, 69120 Heidelberg; Germany

* To whom correspondence should be addressed. E-mail: andreas.vondeimling{at}med.uni-heidelberg.de.


   Abstract

The flavonoid quercetin has been reported to inhibit the proliferation of cancer cells whereas it has no effect on non-neoplastic cells. U87-MG, U251, A172, LN229 and U373 malignant gliomas cells were treated with quercetin (50-200 µM). 24 hours after treatment quercetin did not cause cytotoxicity. Combining quercetin with TNF-related apoptosis-inducing ligand (TRAIL) strongly augmented TRAIL-mediated apoptosis in U87-MG, U251, A172, LN229 glioma cells. U373 cells could not be sensitized by quercetin to TRAIL-mediated apoptosis. We demonstrated that TRAIL-induced apoptosis is enhanced by quercetin-induced reduction of survivin protein levels. Upon treatment with quercetin the protein level of survivin was strongly suppressed in U87-MG, U251, A172, but not in U373 glioma cells. Quercetin exposure resulted in proteasomal degradation of survivin. TRAIL-quercetin induced apoptosis was markedly reduced by over-expression of survivin. In addition, we demonstrated that upon treatment with quercetin down-regulation of survivin was also regulated by the Akt pathway. Taken together, the present study suggests that quercetin sensitizes glioma cells to death-receptor mediated apoptosis by suppression of inhibitor of apoptosis proteins survivin.

Key Words: glioma, quercetin, TRAIL, survivin, apoptosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





  Home | Help | Feedback | Subscriptions | Archive | Search | Advance Publication


Copyright 2008 by Society for Neuro-Oncology